老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

77.51
-0.1900-0.24%
盘后：77.510.00000.00%19:53 EDT
成交量：91.78万
成交额：7,095.87万
市值：150.26亿
市盈率：-20.51
高：78.45
开：77.21
低：76.28
收：77.70
52周最高：84.94
52周最低：31.77
股本：1.94亿
流通股本：1.51亿
量比：0.46
换手率：0.61%
股息：- -
股息率：- -
每股收益(TTM):-3.7800
每股收益(LYR):-3.7850
净资产收益率：-1789.67%
总资产收益率：-33.83%
市净率：-7.20
市盈率(LYR):-20.48

数据加载中...

总览公司新闻资讯公告
2021/01/04

重要事件披露

8-K - Current report
2020/12/11

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/06

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/06

重要事件披露

8-K - Current report
2020/11/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/05

重要事件披露

8-K - Current report
2020/10/23

重要事件披露

8-K - Current report
2020/10/15

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/10/06

重要事件披露

8-K - Current report
2020/10/06

企业合并公告

425 - Prospectuses and communications, business combinations
2020/10/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/06

企业合并公告

425 - Prospectuses and communications, business combinations
2020/10/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/05

企业合并公告

425 - Prospectuses and communications, business combinations
2020/10/05

重要事件披露

8-K - Current report
2020/09/29

重要事件披露

8-K - Current report
2020/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/11

重要事件披露

8-K - Current report
2020/07/07

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/24

重要事件披露

8-K - Current report
更多